MOLINDONE HYDROCHLORIDE
Molindone Hydrochloride is indicated for the management of schizophrenia. Its efficacy has been established in clinical trials involving acutely ill patients, including those newly hospitalized and those with a history of chronic hospitalization.
How MOLINDONE HYDROCHLORIDE Works
Molindone hydrochloride is a dihydroindolone antipsychotic. Although its precise mechanism of action has not been fully elucidated, it is believed to exert its effects by blocking postsynaptic dopamine receptors (specifically D2 receptors) in the mesolimbic and mesocortical pathways of the brain. It is pharmacologically distinct from phenothiazines, butyrophenones, and thioxanthenes.
Details
- Status
- Prescription
- First Approved
- 2015-03-20
- Routes
- ORAL
- Dosage Forms
- TABLET
MOLINDONE HYDROCHLORIDE Approval History
What MOLINDONE HYDROCHLORIDE Treats
1 indicationsMOLINDONE HYDROCHLORIDE is approved for 1 conditions since its original approval in 2015. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Schizophrenia
MOLINDONE HYDROCHLORIDE Boxed Warning
WARNING Increased Mortality in Elderly Patients with Dementia-Related Psychosis – Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Analyses of seventeen placebo-controlled trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic drugs, revealed a risk of death in drug-treated patients of between 1.6 to 1.7 times the risk of death in placebo-treated patients. Over the course of a typical 10-week cont...
WARNING Increased Mortality in Elderly Patients with Dementia-Related Psychosis – Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Analyses of seventeen placebo-controlled trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic drugs, revealed a risk of death in drug-treated patients of between 1.6 to 1.7 times the risk of death in placebo-treated patients. Over the course of a typical 10-week controlled trial, the rate of death in drug-treated patients was about 4.5%, compared to a rate of about 2.6% in the placebo group. Although the causes of death were varied, most of the deaths appeared to be either cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia) in nature. Observational studies suggest that, similar to atypical antipsychotic drugs, treatment with conventional antipsychotic drugs may increase mortality. The extent to which the findings of increased mortality in observational studies may be attributed to the antipsychotic drug as opposed to some characteristic(s) of the patients is not clear. Molindone Hydrochloride Tablets, USP are not approved for the treatment of patients with dementia-related psychosis (see WARNINGS ).
MOLINDONE HYDROCHLORIDE Competitive Set
ProThree rings of competition based on shared molecular targets and treated indications.
Indication competitors
Same indication, different mechanism — what else might this patient receive?
Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.
Drugs Similar to MOLINDONE HYDROCHLORIDE
3 of 20FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
MOLINDONE HYDROCHLORIDE FDA Label Details
Indications & Usage
MOLINDONE HYDROCHLORIDE is indicated for the treatment of Schizophrenia.
WARNING Increased Mortality in Elderly Patients with Dementia-Related Psychosis – Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Analyses of seventeen placebo-controlled trials (modal duration of 10 weeks), largely in patients tak...
Looking for the branded version?
MOBAN
Full clinical data, patents, trials, and competitive landscape for molindone hydrochloride.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.